LABORATORIOS FARMACEUTICOS ROVI, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.8 EUR | -1.95% |
|
-1.78% | +37.54% |
| 02/04 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
| 12/03 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
